New: Introducing “Why Is It Moving?” - lightning-fast, AI-driven explanations of stock moves

Learn More
Last Close
Oct 16  •  02:27PM ET
127.29
Dollar change
-2.16
Percentage change
-1.67
%
IndexS&P 500 P/E15.92 EPS (ttm)8.00 Insider Own0.67% Shs Outstand1.74B Perf Week-4.52%
Market Cap221.54B Forward P/E22.45 EPS next Y5.67 Insider Trans-0.07% Shs Float1.73B Perf Month-5.13%
Enterprise Value227.96B PEG1.54 EPS next Q1.49 Inst Own80.07% Short Float1.05% Perf Quarter2.93%
Income13.94B P/S5.05 EPS this Y10.31% Inst Trans0.23% Short Ratio2.82 Perf Half Y-1.86%
Sales43.84B P/B4.38 EPS next Y10.08% ROA17.75% Short Interest18.17M Perf YTD12.53%
Book/sh29.05 P/C30.42 EPS next 5Y10.34% ROE31.01% 52W High141.23 -9.87% Perf Year8.56%
Cash/sh4.18 P/FCF32.70 EPS past 3/5Y24.73% 29.98% ROIC21.95% 52W Low110.86 14.82% Perf 3Y25.10%
Dividend Est.2.38 (1.87%) EV/EBITDA21.28 Sales past 3/5Y-0.88% 5.63% Gross Margin58.38% Volatility2.21% 2.02% Perf 5Y16.09%
Dividend TTM2.36 (1.85%) EV/Sales5.20 EPS Y/Y TTM152.28% Oper. Margin17.75% ATR (14)2.93 Perf 10Y209.25%
Dividend Ex-DateOct 15, 2025 Quick Ratio1.30 Sales Y/Y TTM6.37% Profit Margin31.79% RSI (14)34.85 Recom1.88
Dividend Gr. 3/5Y7.17% 11.16% Current Ratio1.82 EPS Q/Q0.17% SMA20-4.50% Beta0.70 Target Price144.60
Payout29.33% Debt/Eq0.27 Sales Q/Q6.90% SMA50-3.93% Rel Volume1.12 Prev Close129.45
Employees114000 LT Debt/Eq0.26 EarningsOct 15 BMO SMA200-2.19% Avg Volume6.45M Price127.29
IPOMar 01, 1937 Option/ShortYes / Yes EPS/Sales Surpr.-0.21% -0.20% Trades Volume5,576,753 Change-1.67%
Date Action Analyst Rating Change Price Target Change
Oct-10-25Initiated The Benchmark Company Buy $145
Jul-18-25Upgrade Jefferies Hold → Buy $145
Jun-16-25Initiated Leerink Partners Market Perform $143
Oct-08-24Initiated Oppenheimer Outperform $130
Sep-19-24Initiated Piper Sandler Overweight $131
Jul-30-24Downgrade Edward Jones Buy → Hold
May-30-24Initiated Goldman Buy $121
Jul-21-23Upgrade Wolfe Research Underperform → Peer Perform
May-30-23Downgrade Morgan Stanley Overweight → Equal-Weight $112
Apr-20-23Reiterated Wolfe Research Underperform $107 → $103
Today 07:50AM
07:50AM
07:49AM
06:45AM
05:58AM
01:31AM Loading…
01:31AM
Oct-15-25 04:20PM
04:16PM
04:09PM
04:06PM
03:06PM
03:01PM
02:10PM
01:43PM
12:15PM
11:40AM Loading…
11:40AM
11:18AM
10:57AM
10:33AM
10:12AM
09:45AM
09:30AM
08:54AM
08:53AM
08:40AM
08:25AM
08:11AM
07:56AM
07:55AM
07:38AM
07:30AM Loading…
07:30AM
07:30AM
07:30AM
03:19AM
Oct-14-25 07:11PM
07:11PM
07:11PM
07:11PM
07:11PM
07:00PM
01:22PM
07:35AM
07:35AM
Oct-13-25 11:02PM
04:23PM
Oct-12-25 07:46AM
06:00AM
Oct-10-25 08:18PM
01:05PM
09:36AM
09:15AM
09:00AM
08:44AM
Oct-09-25 02:05AM
Oct-08-25 02:17AM
Oct-07-25 04:44AM
Oct-06-25 09:50AM
Oct-03-25 05:50PM
05:24PM
09:30AM
05:54AM
Oct-02-25 07:06AM
02:33AM
Oct-01-25 05:28PM
11:11AM
08:44AM
Sep-30-25 05:01PM
Sep-29-25 12:41PM
09:32AM
09:00AM
05:46AM
Sep-26-25 11:40AM
08:41AM
Sep-25-25 11:16AM
05:40AM
Sep-24-25 06:00PM
11:57AM
09:00AM
Sep-23-25 02:47PM
Sep-21-25 07:05PM
Sep-19-25 11:02AM
09:00AM
08:59AM
05:45AM
Sep-18-25 09:41PM
09:01AM
08:56AM
Sep-16-25 05:50PM
09:30AM
09:00AM
Sep-13-25 06:42AM
Sep-11-25 06:48PM
Sep-10-25 05:50PM
11:40AM
Sep-09-25 09:05AM
Sep-08-25 04:51PM
Sep-07-25 02:37PM
Sep-05-25 08:50AM
Sep-04-25 08:47AM
04:09AM
Abbott Laboratories engages in the discovery, development, manufacture, and sale of healthcare products. It operates through the following segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The Established Pharmaceutical Products segment refers to the line of branded generic pharmaceuticals manufactured worldwide and marketed and sold outside the United States in emerging markets. The Diagnostic Products segment markets diagnostic systems and tests for blood banks, hospitals, commercial laboratories, clinics, physicians' offices, retailers, government agencies, and alternate care testing sites. The Nutritional Products segment caters to the worldwide sales of pediatric and adult nutritional products. The Medical Devices segment includes a broad line of rhythm management, electrophysiology, heart failure, vascular and structural heart devices for the treatment of cardiovascular diseases, and diabetes care and continuous glucose monitoring products, as well as neuromodulation devices for the management of chronic pain and movement disorders. The company was founded by Wallace Calvin Abbott in 1888 and is headquartered in Abbott Park, IL.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Boudreau Philip PEVP AND CFOAug 08 '25Sale134.555,550746,75851,003Aug 11 05:53 PM
Boudreau Philip POfficerAug 08 '25Proposed Sale134.555,550746,758Aug 08 06:30 PM
Blount Sally E.DirectorApr 30 '25Sale129.662,600337,11634,058May 02 05:04 PM
SALLY E BLOUNTDirectorApr 30 '25Proposed Sale129.662,600337,116Apr 30 04:23 PM
Earnhardt Lisa DEVP AND GROUP PRESIDENTMar 06 '25Option Exercise80.9891,1677,382,704163,095Mar 07 06:55 PM
Earnhardt Lisa DEVP AND GROUP PRESIDENTMar 07 '25Option Exercise80.9820016,19672,128Mar 07 06:55 PM
Earnhardt Lisa DEVP AND GROUP PRESIDENTMar 06 '25Sale133.8291,16712,199,96871,928Mar 07 06:55 PM
Earnhardt Lisa DEVP AND GROUP PRESIDENTMar 07 '25Sale136.6520027,32971,928Mar 07 06:55 PM
Lisa D. EarnhardtOfficerMar 07 '25Proposed Sale136.6520027,329Mar 07 06:28 PM
Lisa D. EarnhardtOfficerMar 06 '25Proposed Sale133.8291,16712,199,967Mar 06 05:47 PM
Wainer Andrea FRETIRED EVPMar 03 '25Sale138.17949131,12374,381Mar 04 08:05 PM
Shroff EricSenior Vice PresidentMar 03 '25Sale138.1756277,65231,970Mar 04 08:00 PM
Morrone Louis H.EXECUTIVE VICE PRESIDENTMar 03 '25Sale138.171,111153,50766,878Mar 04 07:49 PM
Moreland Mary KEXECUTIVE VICE PRESIDENTMar 03 '25Sale138.17791109,29295,583Mar 04 07:44 PM
MCCOY JOHN A. JR.VICE PRESIDENT AND CONTROLLERMar 03 '25Sale138.1756277,65221,061Mar 04 07:39 PM
Eric ShroffOfficerMar 03 '25Proposed Sale138.1756277,651Mar 03 08:40 PM
Andrea F. WainerRetired OfficerMar 03 '25Proposed Sale138.17949131,123Mar 03 08:18 PM
Louis H. MorroneOfficerMar 03 '25Proposed Sale138.171,111153,506Mar 03 08:08 PM
Mary K. MorelandOfficerMar 03 '25Proposed Sale138.17791109,292Mar 03 07:58 PM
John A. McCoy, Jr.OfficerMar 03 '25Proposed Sale138.1756277,651Mar 03 07:52 PM
Ford Robert BCHAIRMAN AND CEOFeb 05 '25Option Exercise38.40285,38810,958,899505,447Feb 07 05:51 PM
Ford Robert BCHAIRMAN AND CEOFeb 05 '25Sale131.17285,38837,435,200220,059Feb 07 05:51 PM
Robert B. FordOfficerFeb 05 '25Proposed Sale131.17285,38837,435,238Feb 05 06:52 PM
ALLEN HUBERT LEXECUTIVE VICE PRESIDENTJan 29 '25Option Exercise38.40131,3605,044,224316,166Jan 31 07:16 PM
ALLEN HUBERT LEXECUTIVE VICE PRESIDENTJan 30 '25Option Exercise38.4058,4282,243,635243,234Jan 31 07:16 PM
ALLEN HUBERT LEXECUTIVE VICE PRESIDENTJan 29 '25Sale128.35131,36016,859,675184,806Jan 31 07:16 PM
ALLEN HUBERT LEXECUTIVE VICE PRESIDENTJan 30 '25Sale128.0758,4287,482,629184,806Jan 31 07:16 PM
Salvadori Daniel Gesua SiveEXECUTIVE VICE PRESIDENTJan 30 '25Option Exercise38.4023,771912,806149,468Jan 31 07:08 PM
Salvadori Daniel Gesua SiveEXECUTIVE VICE PRESIDENTJan 30 '25Sale128.5023,7713,054,574125,697Jan 31 07:08 PM
Morrone Louis H.EXECUTIVE VICE PRESIDENTJan 28 '25Sale127.392,644336,8190Jan 30 07:33 PM
Hubert L. AllenOfficerJan 30 '25Proposed Sale128.0758,4287,482,628Jan 30 05:33 PM
Daniel Gesua Sive SalvadoriOfficerJan 30 '25Proposed Sale128.5023,7713,054,573Jan 30 05:26 PM
Hubert L. AllenOfficerJan 29 '25Proposed Sale128.35131,36016,859,675Jan 29 05:30 PM
Funck, Jr. Robert E.OfficerNov 04 '24Proposed Sale120.0015,0001,800,000Nov 04 04:02 PM
ALLEN HUBERT LEXECUTIVE VICE PRESIDENTOct 21 '24Option Exercise47.00157,4217,398,787342,227Oct 23 05:10 PM
ALLEN HUBERT LEXECUTIVE VICE PRESIDENTOct 21 '24Sale117.04157,42118,424,298184,806Oct 23 05:10 PM
ALLEN HUBERT LOfficerOct 21 '24Proposed Sale118.89157,42118,715,783Oct 21 04:08 PM